CASC9 and esophageal squamous cell carcinoma: For instance, in ESCC, the stimulatory effects of CASC9 on proliferation and the cell cycle have been ascribed to recruitment of the histone methyltransferase EZH2 which then downregulates the pro-apoptotic protein PDCD4 [11].